Dopaminergic drugs in development for Parkinson's disease

被引：0
|
作者：
Korczyn, AD [1 ]
机构：
[1] Tel Aviv Univ, Sch Med, Sieratzki Chair Neurol, Ramat Aviv, Israel
来源：
PARKINSON'S DISEASE | 2003年 / 91卷
关键词：
D O I：
暂无
中图分类号：
Q3 [遗传学];
学科分类号：
071007 ; 090102 ;
摘要：
引用
收藏
页码：267 / 271
页数：5
相关论文
共 50 条
  • [1] Parkinson's disease, dopaminergic drugs and the plant world
    Kempster, Peter
    Ma, Andrew
    FRONTIERS IN PHARMACOLOGY, 2022, 13
  • [2] Mirror movements in Parkinson's disease: effect of dopaminergic drugs
    Espay, A. J.
    Morgante, F.
    Gunraj, C.
    Chen, R.
    Lang, A. E.
    JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY, 2006, 77 (10): : 1194 - 1195
  • [3] Peripheral markers of apoptosis in Parkinson's disease the effect of Dopaminergic drugs
    Blandini, F
    Mangiagalli, A
    Cosentino, M
    Marino, M
    Samuele, A
    Rasini, E
    Fancellu, R
    Martignoni, E
    Riboldazzi, G
    Calandrella, D
    Frigo, GM
    Nappi, G
    APOPTOSIS: FROM SIGNALING PATHWAYS TO THERAPEUTIC TOOLS, 2003, 1010 : 675 - 678
  • [4] Influence of dopaminergic drugs on fatigue syndrome in patients with Parkinson's disease
    Datieva, V.
    Levin, O.
    JOURNAL OF NEUROLOGY, 2013, 260 : S144 - S145
  • [5] Drugs in development for Parkinson's disease: An update
    Johnston, TH
    Brotchie, JM
    CURRENT OPINION IN INVESTIGATIONAL DRUGS, 2006, 7 (01) : 25 - 32
  • [6] Development of dopaminergic neurons in zebrafish: A model of Parkinson's disease
    Hung, Karen W. Y.
    NEUROSCIENCE RESEARCH, 2008, 61 : S266 - S266
  • [7] Non-dopaminergic treatments in development for Parkinson's disease
    Fox, Susan H.
    Brotchie, Jonathan M.
    Lang, Anthony E.
    LANCET NEUROLOGY, 2008, 7 (10): : 927 - 938
  • [8] Dopaminergic drugs, paraphilic fantasies, paraphilic behaviours and creativity in Parkinson's disease
    Cannas, Antonino
    Solla, Paolo
    Floris, Gian Luca
    Serra, Claudia
    Costantino, Emanuela
    Piras, Valeria
    Marrosu, Francesco
    Marrosu, Maria Giovanna
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 2010, 34 (03): : 563 - 564
  • [9] Acoustic voice analysis in patients with Parkinson's disease treated with dopaminergic drugs
    Gamboa, J
    JimenezJimenez, F
    Nieto, A
    Montojo, J
    OrtiPareja, M
    Molina, JA
    GarciaAlbea, E
    Cobeta, I
    JOURNAL OF VOICE, 1997, 11 (03) : 314 - 320
  • [10] Constant dopaminergic stimulation by transdermal delivery of dopaminergic drugs: a new treatment paradigm in Parkinson's disease
    Steiger, M.
    EUROPEAN JOURNAL OF NEUROLOGY, 2008, 15 (01) : 2 - 11
12345